Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
30.49
+1.69 (5.87%)
Apr 23, 2025, 4:00 PM EDT - Market closed
RGC Market Cap
RGC has a market cap or net worth of $396.76 million as of April 23, 2025. Its market cap has increased by 428.42% in one year.
Market Cap
396.76M
Enterprise Value
388.89M
1-Year Change
428.42%
Ranking
Category
Stock Price
$30.49
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has increased from $120.10M to $396.76M, an increase of 230.36%. That is a compound annual growth rate of 37.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 396.76M | 517.21% |
| Dec 31, 2024 | 64.28M | -52.95% |
| Dec 29, 2023 | 136.64M | -62.35% |
| Dec 29, 2022 | 362.93M | -12.12% |
| Dec 31, 2021 | 413.00M | 243.88% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.93B |
| UnitedHealth Group | 392.07B |
| Johnson & Johnson | 375.04B |
| AbbVie | 298.48B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 223.16B |
| Novartis AG | 209.93B |
| AstraZeneca | 208.11B |